The Wall Street Transcript is a completely unique resource for investors and business researchers.

Please tell us about Puma Biotechnology. Mr. Auerbach: I’d be more than happy to. Puma is a biotech company that is dedicated to the development and commercialization of drugs for the treatment of ...

Let’s start with an overview of the company and some notable milestones. Mr. Levy: Sure. You know, a major challenge for cancer patients and their caregivers today is that while we’ve seen incredible ...

We’ve spoken before, but just for readers who may not be familiar, let’s start with a refresher on the company, its mission, and some milestones. Mr. Do: BioVie has two assets that we are currently ...

Steven M. Lichtman is Managing Director and Senior Analyst for medical devices at Oppenheimer & Co. Inc. Mr. Lichtman has been on the sell side following the medical devices sector for over 20 ...

Ilan Sobel has been the CEO of BioHarvest Sciences Inc. since July 2020. He brought the company’s first product, VINIA, to North America, building a direct-to-consumer machine that is now ...

Vlad Vitoc, M.D., is Chairman of Board, Chief Executive Officer, and President of MAIA Biotechnology Inc. Dr. Vitoc has a broad array of experience across commercial strategic analysis and ...

Erez Aminov is the Chairman and Chief Executive Officer of MIRA Pharmaceuticals, Inc., a biopharmaceutical company developing treatments for neuropsychiatric disorders. In addition, Mr. Aminov ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Hartaj Singh is a Founding Partner of Tecumseh Partners, advising biotech companies on valuation, strategy, and investor engagement. He also writes The Biotech Capital Compass, a newsletter ...